Cargando…
The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity
BACKGROUND: Doxorubicin (DOX) is a very effective anticancer medication that is commonly used to treat hematological malignancies and solid tumors. Nevertheless, DOX is known to have cardiotoxic effects that may lead to cardiac dysfunction and failure. In experimental studies, female animals have be...
Autores principales: | Zordoky, Beshay N., Radin, M. Judith, Heller, Lois, Tobias, Anthony, Matise, Ilze, Apple, Fred S., McCune, Sylvia A., Sharkey, Leslie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533296/ https://www.ncbi.nlm.nih.gov/pubmed/28758028 http://dx.doi.org/10.1186/s40959-016-0013-3 |
Ejemplares similares
-
Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice
por: Grant, Marianne K. O., et al.
Publicado: (2019) -
Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation
por: Grant, Marianne K.O., et al.
Publicado: (2020) -
Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice
por: Grant, Marianne K. O., et al.
Publicado: (2017) -
Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
por: Meiners, Becky, et al.
Publicado: (2018) -
Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction
por: Grant, Marianne K. O., et al.
Publicado: (2020)